T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Intel
INTC
|
+$1.59B |
| 2 |
Dollar General
DG
|
+$1.53B |
| 3 |
Charles Schwab
SCHW
|
+$1.19B |
| 4 |
Uber
UBER
|
+$971M |
| 5 |
Nike
NKE
|
+$868M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.83B |
| 2 |
Amazon
AMZN
|
+$2.33B |
| 3 |
NVIDIA
NVDA
|
+$1.75B |
| 4 |
Humana
HUM
|
+$1.46B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Akebia Therapeutics
AKBA
$830M
| $75K | ﹤0.01% |
59,900
| – | – |
|
2752
Summit Therapeutics
SMMT
$14.4B
| $74K | ﹤0.01% |
28,006
+1,059
| +4% | +$2.8K |
|
2753
Advantage Solutions
ADV
$626M
| $74K | ﹤0.01% |
20,423
+882
| +5% | +$3.2K |
|
2754
Fossil Group
FOSL
$160M
| $74K | ﹤0.01% |
50,388
+18,900
| +60% | +$27.8K |
|
2755
CEL-SCI Corp
CVM
$71.2M
| $73K | ﹤0.01% |
893
| – | – |
|
|
ME
2756
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $73K | ﹤0.01% |
3,986
+850
| +27% | +$15.6K |
|
2757
Nektar Therapeutics
NKTR
$843M
| $71K | ﹤0.01% |
8,317
| – | – |
|
2758
XBiotech
XBIT
$83.5M
| $71K | ﹤0.01% |
17,600
| – | – |
|
2759
SoundHound AI
SOUN
$6.23B
| $70K | ﹤0.01% |
32,617
+1,771
| +6% | +$3.8K |
|
2760
Seer Inc
SEER
$114M
| $67K | ﹤0.01% |
34,139
-1,093,079
| -97% | -$2.15M |
|
2761
Lantronix
LTRX
$187M
| $66K | ﹤0.01% |
11,200
| – | – |
|
|
QVCGA
2762
QVC Group, Inc. Series A Common Stock
QVCGA
$79M
| $66K | ﹤0.01% |
1,491
-1,604
| -52% | -$71K |
|
|
NXDR
2763
Nextdoor Holdings
NXDR
$778M
| $65K | ﹤0.01% |
34,090
+2,488
| +8% | +$4.74K |
|
2764
Workhorse Group
WKHS
$18.4M
| $65K | ﹤0.01% |
722
+360
| +99% | +$32.4K |
|
2765
Rayonier Advanced Materials
RYAM
$403M
| $63K | ﹤0.01% |
15,379
+1,559
| +11% | +$6.39K |
|
2766
Safe Bulkers
SB
$456M
| $63K | ﹤0.01% |
15,816
+441
| +3% | +$1.76K |
|
|
ENZ
2767
DELISTED
Enzo Biochem, Inc.
ENZ
| $63K | ﹤0.01% |
44,800
| – | – |
|
2768
Olaplex Holdings
OLPX
$987M
| $62K | ﹤0.01% |
24,343
+2,901
| +14% | +$7.39K |
|
2769
Quantum Corp
QMCO
$101M
| $62K | ﹤0.01% |
8,760
| – | – |
|
2770
Rumble
RUM
$2.48B
| $62K | ﹤0.01% |
13,700
| – | – |
|
2771
Sutro Biopharma
STRO
$83.3M
| $62K | ﹤0.01% |
14,449
+1,335
| +10% | +$5.73K |
|
2772
Bionano Genomics
BNGO
$19.9M
| $60K | ﹤0.01% |
525
+342
| +187% | +$39.1K |
|
2773
Destination XL Group
DXLG
$67.9M
| $60K | ﹤0.01% |
13,595
+839
| +7% | +$3.7K |
|
2774
Holley
HLLY
$451M
| $60K | ﹤0.01% |
12,276
+814
| +7% | +$3.98K |
|
2775
Standard BioTools
LAB
$520M
| $60K | ﹤0.01% |
26,800
-11,600
| -30% | -$26K |
|